Bridgestone Corporation

Aeris Therapeutics, Inc.

Biosphere Medical, Sa

Pulmonx Corporation

Biosphere Medical, Inc.

James A Krom

Xiaorong Wang

James E Hall

Alexander Schwarz

Edward P Ingenito

Larry W Tsai

Chenchy Jeffrey Lin

Koichi Morita

Hajime Kondo

Sandra M Warren

Philippe Reb

Marion Pierre

Barbara De Gioannis

William L Hergenrother

Terrence Eugene Hogan

Georg G A Böhm

Peyman Pakdel

Provided herein, for example, are microspheres comprising a gelatin or gelatin substitute and a copolymer of a N-tris-hydroxymethyl methylacrylamide monomer unit, a diethylaminoethylacrylamide monomer unit and a N,N-methylene-bis-acrylamide monomer unit. Also provided are methods of producing microspheres comprising a gelatin or gelatin substitute and a copolymer of a N-tris-hydroxymethyl methylacrylamide monomer unit, a diethylaminoethylacrylamide monomer unit and a N,N-methylene-bis-acrylamide monomer unit. Further provided herein, for example, are compositions comprising the microspheres and methods of using the microspheres and compositions thereof.

Microspheres useful for therapeutic vascular embolization

One aspect of the invention relates to a hydrogel comprising a non-natural polymer comprising a plurality of pendant nucleophilic groups and a crosslinker comprising at least two pendant electrophilic groups. Another aspect of the invention relates to a hydrogel comprising a non-natural polymer comprising a plurality of pendant electrophilic groups and a crosslinker comprising at least two pendant nucleophilic groups. Yet another aspect of the invention relates to a method for reducing lung volume in a patient comprising the step of administering a hydrogel composition as described herein. Further, hydrogels of the invention may be used to achieve pleurodesis, seal brochopleural fistulas, seal an air leak in a lung, achieve hemostasis, tissue sealing (e.g., blood vessels, internal organs), or any combination thereof. In certain embodiments, the compositions and methods described herein are intended for use in the treatment of patients with emphysema.

Lung volume reduction therapy using crosslinked non-natural polymers

A nano-particle composition including a poly(alkenylbenzene) core and a poly (conjugated diene) or a poly(alkylene) surface layer is provided. The nano-particles have a mean average diameter less than about 100 nm. The nano-particles can be modified via, for example, hydrogenation or functionalization. The nano-particles can advantageously be incorporated into rubbers, elastomers, and thermoplastics.

Nano-particle preparation and applications

A nano-particle composition including a poly(alkenylbenzene) core and a poly(conjugated diene), a poly(alkylene), or a poly(alkenylbenzene) surface layer is provided. The nano-particles have a mean average diameter of less than about 100 nm. The nano-particles can be modified via, for example, hydrogenation or functionalization. The nano-particles can be advantageously be incorporated into rubbers, elastomers, and thermoplastics.

A polymer nano-particle composition is provided, wherein the nano-particle includes a poly(alkenylbenzene) core and a surface layer including poly(conjugated diene). A method for self-assembly of the nano-particles is also provided. The polymer nano-particles are preferably less than about 100 nm in diameter.

Self assembly of molecules to form nano-particles

A reaction product is prepared by reacting a first polymer having pendant or terminal carboxyl or anhydride groups with a second polymer (e.g. elastomer) having an amine containing terminal group. The second polymer is anionically polymerized. The second polymer is functionalized by reacting the growing anionic chain end with an imine. Then a protic terminating agent terminates the growing chain end. The first and second polymers are reacted by mixing (desirably above their softening temperatures) and forming a blend with improved physical properties over a blend of similar polymers lacking a reactive amine group.

Reaction product derived from amine-functionalized elastomers and maleated polyolefins

A nano-particle composition including a poly (alkenylbenzene) core and a poly (conjugated diene) or a poly(alkylene) surface layer is provided. The nano-particles have a mean average diameter less than about 100 nm. The nano-particles can be modified via, for example, hydrogenation or functionalization. The nano-particles can advantageously be incorporated into rubbers, elastomers, and thermoplastics.

A composition comprising an elastomer, a filler, and a comb-like polymer, the comb-like polymer comprising a backbone and a plurality of side chains, the backbone having a length greater than or equal to the entanglement length, the side chains having a length greater than about 33% of the entanglement length, the backbone including at least one side chain per entanglement length, and the comb-like polymer having a T of less than &minus;5&deg; C.

Rubber compositions & vulcanizates including comb polymers

A polymer nano-particle composition is provided, wherein the nano-particle includes a poly(alkenylbenzene) core and a surface layer including poly(conjugated diene). The polymer nano-particles are preferably less than about 100 nm in diameter. The nano-particles can be made by a dispersion polymerization process.

Growing community of inventors

Cleveland Heights, OH, United States of America

James A Krom